TUO0 logo

Terumo DB:TUO0 Stock Report

Last Price

€17.80

Market Cap

€27.3b

7D

1.7%

1Y

n/a

Updated

13 Nov, 2024

Data

Company Financials +

TUO0 Stock Overview

Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.

TUO0 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for TUO0 from our risk checks.

Terumo Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Terumo
Historical stock prices
Current Share PriceJP¥17.80
52 Week HighJP¥32.20
52 Week LowJP¥12.90
Beta0.41
11 Month Change2.30%
3 Month Change12.66%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-40.27%

Recent News & Updates

Recent updates

Shareholder Returns

TUO0DE Medical EquipmentDE Market
7D1.7%3.8%-1.2%
1Yn/a-2.9%9.0%

Return vs Industry: Insufficient data to determine how TUO0 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how TUO0 performed against the German Market.

Price Volatility

Is TUO0's price volatile compared to industry and market?
TUO0 volatility
TUO0 Average Weekly Movement4.2%
Medical Equipment Industry Average Movement4.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: TUO0 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: TUO0's weekly volatility has decreased from 10% to 4% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1921n/aHikaru Samejimawww.terumo.com

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.

Terumo Corporation Fundamentals Summary

How do Terumo's earnings and revenue compare to its market cap?
TUO0 fundamental statistics
Market cap€27.27b
Earnings (TTM)€727.24m
Revenue (TTM)€6.01b

37.5x

P/E Ratio

4.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TUO0 income statement (TTM)
RevenueJP¥986.67b
Cost of RevenueJP¥456.87b
Gross ProfitJP¥529.80b
Other ExpensesJP¥410.32b
EarningsJP¥119.49b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)80.70
Gross Margin53.70%
Net Profit Margin12.11%
Debt/Equity Ratio13.3%

How did TUO0 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

30%

Payout Ratio